Sort
40,608 grants matching “prostate cancer”
Collaborative Systems for Analyzing Tissue Microarrays
$344,841David J Foran · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2012 · CA
Obesogenic environment: impact on breast, colorectal, and prostate cancer risk
$344,827Iona C Cheng · University Of Hawaii At Manoa · R01 · FY2011 · CA
Project 2: Integrating a Novel MiPS-Based Next-Generation Sequencing Urine Assay for the Early Detection of Unfavorable Risk Prostate Cancer
$344,822Ganesh S Palapattu · University Of Michigan At Ann Arbor · P50 · FY2021 · CA
THE ROLE OF MITOCONDRIAL TCA CYCLE ENZYMES IN DETERMINING PROSTATE CANCER CHEMOSENSITIVITY
$344,696Oregon Health & Science University · · FY2010 · Department of the Army
Targeting Endoplasmic Reticulum Stress Response for Cancer Therapy
$344,687Bertal H. Aktas · Brigham And Women'S Hospital · R01 · FY2014 · CA
Project 2: Re-directing the Sensitivity of Metastatic Castration-Resistant Prostate Cancer to Immunotherapy
$344,686Jennifer D Wu · Northwestern University At Chicago · P50 · FY2024 · CA
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
$344,669James P Quigley · Scripps Research Institute, The · R01 · FY2009 · CA
Role of Id1 in NSCLC Progression and Metastasis
$344,596Srikumar P Chellappan · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2012 · CA
MR Signal Amplification for Receptor Imaging
$344,571Alexei A Bogdanov · Univ Of Massachusetts Med Sch Worcester · R01 · FY2010 · EB
SOUTHWEST ONCOLOGY GROUP--OPERATIONS OFFICER
$344,561Cancer Therapy And Research Center · U10 · FY2000 · CA
Understanding how ZFHX4 drives the glioblastoma tumor propagating cell state
$344,531Milan Girish Chheda · Washington University · R01 · FY2021 · NS
Understanding how ZFHX4 drives the glioblastoma tumor propagating cell state
$344,531Milan Girish Chheda · Washington University · R01 · FY2022 · NS
Specific Recognition of G-quadruplexes
$344,481Hanbin Mao · Kent State University · R01 · FY2018 · CA
Drug Development of Ribonucleotide Reductase Inhibitor
$344,450Yun Yen · Beckman Research Institute/City Of Hope · R01 · FY2010 · CA
Deciphering the function of the APE2 nuclease during repair by alternative end-joining and its role in HR-deficient cells
$344,450Nausica C. Arnoult · University Of Colorado · R01 · FY2023 · CA
Mechanisms of Carcinoma Differentiation and Invasion
$344,450Arthur M Mercurio · Univ Of Massachusetts Med Sch Worcester · R01 · FY2012 · CA
Drug Development of Ribonucleotide Reductase Inhibitor
$344,450Yun Yen · Beckman Research Institute/City Of Hope · R01 · FY2009 · CA
Understanding how ZFHX4 drives the glioblastoma tumor propagating cell state
$344,441Milan Girish Chheda · Washington University · R01 · FY2020 · NS
MiR-183-96-182 cluster, prostatic zinc homeostasis and carcinogenesis
$344,440Larisa Nonn · University Of Illinois At Chicago · R01 · FY2012 · CA
PREVENTION OF PROSTATE CARCINOGENESIS BY NEXT-GENERATION SELENIUM
$344,401Junxuan Lu · Texas Tech University Health Scis Center · R01 · FY2013 · CA
APT: the Analytical Proteomics Team
$344,400Fred E Regnier · Purdue University · U24 · FY2009 · CA
MiRNAs/UCRs: biomarkers for cancer risk, tumor detection, progression & treatment
$344,369Carlo M Croce · Ohio State University · U01 · FY2014 · CA
CPE Peptide-Based Nanoparticles for the Diagnosis and Therapy of Chemotherapy Res
$344,277Alessandro D Santin · Yale University · R01 · FY2012 · CA
Neuropilin-2 Axis in Docetaxel Resistance and Prostate Cancer Bone Metastasis
$344,269Kaustubh Datta · University Of Nebraska Medical Center · R01 · FY2016 · CA
Suppression of Prostate Tumor Growth and Metastasis by Inhibition of Vimentin
$344,269Vivek M Rangnekar · University Of Kentucky · R01 · FY2016 · CA